PART I ANI Pharmaceuticals is a diversified bio-pharmaceutical company. The Company's mission is Serving Patients, Improving Lives by developing, manufacturing, and commercializing therapeutics through its Rare Disease, Generics, and Brands businesses. On September 16, 2024, the Company acquired Alimera Sciences, Inc. ("Alimera"). In connection with the acquisition, the Company added two new products, ILUVIEN ("ILUVIEN") and YUTIQ ("YUTIQ"). See Note 3 "Business Combination" in the notes to the ...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001023024-26-000014 | EDGAR | 98K words |
| 2025-02-28 | 2024-12-31 | 0001023024-25-000015 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001023024-24-000026 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001023024-23-000005 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001023024-22-000004 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001023024-21-000007 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001104659-20-025744 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001144204-19-010541 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001144204-18-011197 | EDGAR | — |
| 2017-03-02 | 2016-12-31 | 0001144204-17-012507 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001023024-25-000108 | EDGAR | 39K words |
| 2025-08-08 | 2025-06-30 | 0001023024-25-000082 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001023024-25-000046 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001023024-24-000102 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001023024-24-000085 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001023024-24-000057 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001023024-23-000043 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001023024-23-000017 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001023024-23-000010 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001023024-22-000021 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001023024-22-000017 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001023024-22-000008 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001023024-26-000017 | EDGAR | 5K words |
| 2026-02-27 | 0001023024-26-000013 | EDGAR | — |
| 2026-01-12 | 0001023024-26-000005 | EDGAR | — |
| 2025-12-01 | 0001023024-25-000113 | EDGAR | — |
| 2025-11-10 | 0001023024-25-000110 | EDGAR | — |
| 2025-11-07 | 0001023024-25-000107 | EDGAR | — |
| 2025-09-26 | 0001023024-25-000099 | EDGAR | — |
| 2025-09-08 | 0001023024-25-000089 | EDGAR | — |
| 2025-08-08 | 0001023024-25-000081 | EDGAR | — |
| 2025-07-29 | 0001104659-25-071769 | EDGAR | — |
271 total filings indexed. 239 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001023024 |
| Ticker | ANIP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.anipharmaceuticals.com |
| Listed | 1999-09-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report